Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

Chinese medicines may be helpful in treating side effects of chemotherapy and symptoms of flu

New research reviews hint that traditional Chinese medicines may be helpful in treating side effects of chemotherapy and symptoms of flu. For now, however, the findings remain more tantalizing than conclusive.

24 Jan 2005

World-first advertising campaign warns women about the health impacts, and ineffectiveness, of fad diets

A world-first advertising campaign that warns women about the health impacts, and ineffectiveness, of fad diets has been launched by the Australian Health Minister, Bronwyn Pike.

18 Jan 2005

Potential cure for lymphoma in HIV patients

Stem cell transplants have become the standard of care for patients with relapsed lymphoma, but not for patients who suffer from both this disease and HIV.

7 Jan 2005

Discovery of new compound known as SP-4-84 could lead to improved chemotherapy treatments

The discovery of a new compound by Michigan State University researchers could lead to improved chemotherapy treatments for different types of cancers – potentially with fewer side effects.

20 Dec 2004

New advances in sickle cell disease

Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.

6 Dec 2004

Single dose phase I data on CG53135 for the prevention of oral mucositis

CuraGen Corporation has announced results presented from a Phase I clinical trial with CG53135 for the prevention of oral mucositis (OM) in patients receiving high dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (AHSCT) at the ASH 46th Annual Meeting in San Diego, CA.

5 Dec 2004

Phase 3 results of Genasense plus Dexamethasone in patients with advanced multiple myeloma

Genta Incorporated announced that results from the Company's randomized Phase 3 clinical trial of Genasense(R) (oblimersen sodium) Injection in patients with relapsed or refractory multiple myeloma were presented today at the annual meeting of the American Society of Hematology (ASH) in San Diego, CA.

4 Dec 2004

Study focused on patients with chemotherapy-related anemia

Findings from an interim analysis of a new study comparing the hemoglobin response rates of Epoetin alfa and darbepoetin alfa in the treatment of chemotherapy-related anemia were published in the November 15, 2004 issue of the Medical Journal 'Blood' as part of the American Society of Hematology 46th Annual Meeting and Exposition.

4 Dec 2004

Pennsylvania confirms first influenza case

Pennsylvania Health Secretary Dr. Calvin B. Johnson has announced that a 13-year-old Philadelphia County teen has the season's first, lab-confirmed case of flu.

4 Dec 2004

Novel anti-obesity compound shows promise for treatment of obesity

Arena Pharmaceuticals announced today results from the dosing phase of its Phase 1b clinical trial of APD356, an orally administered small molecule designed to regulate satiety (and perhaps metabolism) for the treatment of obesity.

30 Nov 2004

Potential vaccine for the deadly toxin ricin

A potential vaccine for the deadly toxin ricin, a "Category B" biological agent, will enter the first phase of clinical testing in coming weeks at UT Southwestern Medical Center at Dallas.

30 Nov 2004

FDA approves Combunox tablets for the short-term treatment of acute, moderate to severe pain

Forest Laboratories have announced that Combunox (Oxycodone HCl and Ibuprofen) Tablets (CII), the first and only fixed-dose combination of the opioid oxycodone HCl (5 mg) and the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (400 mg), was approved by the U.S. Food and Drug Administration (FDA) for the short-term management of acute, moderate to severe pain.

29 Nov 2004

Study finds that stomach cancer originates from bone marrow derived stem cells, rather than from stomach stem cells

A common assumption among cancer specialists is that most cancers originate from tissue stem cells – for example, the gastric stem cells contained in the lining of the stomach.

29 Nov 2004

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.

24 Nov 2004

Capsules may be effective in treating bipolar disorder

University of North Carolina at Chapel Hill researchers have announced study results finding that a formulation of three-beaded extended-release carbamazepine capsules (ERC-CBZ) was effective, safe and tolerable in the treatment of bipolar I disorder

19 Nov 2004

Trial of new type of drug that attacks amyloid

Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer’s disease patients.

4 Nov 2004

European approval for Taxotere (docetaxel) in prostate cancer

Aventis, part of the sanofi-aventis Group announced today that the European Commission has approved Taxotere (docetaxel) Injection Concentrate for use in combination with prednisone as a treatment for men with androgen-independent (hormone- refractory) metastatic prostate cancer.

4 Nov 2004

Health professionals fall short for Hepatitis C patients

People living with Hepatitis C are highly critical of the treatment they have received from health professionals, particularly doctors, according to a new study by a University of Auckland sociology researcher.

3 Nov 2004

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

A team of scientists at Tufts University School of Veterinary Medicine has helped decode the genome sequence of Cryptosporidium hominis, an insidious parasite identified as one of the most common causes of waterborne diseases in humans and classified by the Centers for Disease Control and Prevention as a potential bioterrorist agent.

29 Oct 2004

Brief psychological interventions are effective in relieving traumatic stress symptoms in family members

Family therapy and other psychological treatments may help reduce symptoms of post-traumatic stress among teenaged survivors of childhood cancer--as well as among their parents.

28 Oct 2004

Nausea News and Research

Further Reading

Chinese medicines may be helpful in treating side effects of chemotherapy and symptoms of flu

World-first advertising campaign warns women about the health impacts, and ineffectiveness, of fad diets

Potential cure for lymphoma in HIV patients

Discovery of new compound known as SP-4-84 could lead to improved chemotherapy treatments

New advances in sickle cell disease

Single dose phase I data on CG53135 for the prevention of oral mucositis

Phase 3 results of Genasense plus Dexamethasone in patients with advanced multiple myeloma

Study focused on patients with chemotherapy-related anemia

Pennsylvania confirms first influenza case

Novel anti-obesity compound shows promise for treatment of obesity

Potential vaccine for the deadly toxin ricin

FDA approves Combunox tablets for the short-term treatment of acute, moderate to severe pain

Study finds that stomach cancer originates from bone marrow derived stem cells, rather than from stomach stem cells

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

Capsules may be effective in treating bipolar disorder

Trial of new type of drug that attacks amyloid

European approval for Taxotere (docetaxel) in prostate cancer

Health professionals fall short for Hepatitis C patients

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

Brief psychological interventions are effective in relieving traumatic stress symptoms in family members

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News